Advanced Technologies & Treatments for Diabetes (ATTD) 2nd Asian Conference on Innovative Therapies for Diabetes Management

Advanced Technologies & Treatments for Diabetes (ATTD) 2nd Asian Conference on Innovative Therapies for Diabetes Management is organized by Kenes Group, Advanced Technologies & Treatments for Diabetes (ATTD) will be held from Dec 09 - 11, 2025 at Suntec Singapore Convention & Exhibition Centre, Singapore.

Description:

• Building on the success of last year’s inaugural event, ATTD continues to lead the way in advancing diabetes care. We are excited to invite you to be part of this groundbreaking conference that will bring together experts from across the globe.
• Join us for 2.5 dynamic days of collaboration and innovation, where clinicians, researchers, diabetes care providers, industry leaders, investors, reimbursement authorities, regulators, and people with diabetes will come together to drive progress in diabetes management at an unprecedented pace.
• As pioneers in the field, your role is critical. ATTD-ASIA 2025 will provide a unique platform for knowledge exchange, collaboration, and groundbreaking advancements. Expect a series of engaging presentations and discussions on cutting-edge topics, including latest AI innovations that relate to the field of Diabetes, glucose sensors, closed-loop systems, new medications, and much more, delivered by leading professionals in the field.

Educational Objectives:
After participating in this educational event, learners should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Evaluate the role of continuous glucose monitoring (CGM) in diagnosing and managing prediabetes and type 2 diabetes.
• Assess the impact of artificial intelligence (AI) and wearable devices in early detection and personalized treatment of type 1 diabetes.
• Integrate digital health tools and decision support systems to enhance patient engagement and adherence in diabetes care.
• Apply nutritional strategies guided by CGM data to optimize glycemic control in individuals with diabetes.
• Address the challenges and opportunities in initiating artificial intelligence-driven diabetes management in Southeast Asia.
• Explore innovative approaches to diabetes care in remote regions, focusing on accessibility and resource optimization.
• Advocate for global access to advanced diabetes technologies.